Key points are not available for this paper at this time.
Supplementary Figure S1. Analytical workflow for the C-CAT, GENIE, and TCGA cohorts.Supplementary Figure S2. Comparison of targeted gene panels.Supplementary Figure S3. Comparison of genetic alterations in C-CAT and GENIE cohorts.Supplementary Figure S4. Comparison of mutation frequency, type, and position in C-CAT and GENIE cohorts.Supplementary Figure S5. Co-occurring and mutually exclusive relationships across cohorts.Supplementary Figure S6. Co-occurring and mutually exclusive relationships across cancer types/subtypes.Supplementary Figure S7. Co-occurring and mutually exclusive relationships using a permutation approach.Supplementary Figure S8. Co-occurring and mutually exclusive relationships across driver mutations in epigenetic regulators.Supplementary Figure S9. Functional and prognostic relevance of driver mutations in epigenetic regulators.
Horie et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: